> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Boston Scientific Vercise Genus Brain Stimulator OK’d
- URL: https://www.fdaweb.com/boston-scientific-vercise-genus-brain-stimulator-okd/
- Published: 2021-01-22T12:00:00.000Z
- Updated: 2026-09-14T16:43:53.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5148505

FDA has approved a Boston Scientific PMA for its fourth-generation Vercise Genus Deep Brain Stimulation (DBS) System. The approval covers conditional use in a magnetic resonance imaging environment. The Bluetooth-enabled, rechargeable and non-rechargeable device includes an implantable pulse generator that powers the Cartesia Directional Leads to provide symptom relief in patients with Parkinson's disease, according to the company. It is designed to deliver targeted electrical stimulation via surgically-implanted leads in the brain connected to the pulse generator..

“The fourth generation of the DBS system since 2012, Vercise Genus builds upon rapid and meaningful innovations in battery longevity, directionality, and stimulation capabilities,” Boston Scientific says. “Through a strategic collaboration, the Brainlab platform provides enhanced visualization capabilities that enable clinicians to see lead placement within the context of each patient's segmented target anatomy.”